Sands Capital Alternatives, LLC
ARLINGTON, VA · CIK 1846444 · 13F filing filed 2022-08-12
SEC-registered investment adviser since 2011 · limited liability company
- Assets managed$5.4bn
- Staff182 · 66 in investment roles
- Main clients (by assets)Private funds 97%, Pension plans 3%
- Private funds34 · $3.7bn gross assets
- Websitesandscapital.com
- Form ADV · 2026-07-28SEC adviser record
- Legal entitySANDS CAPITAL ALTERNATIVES, LLC (US)
- Kindhedge funds, private equity, venture, futures, wealth
- Others nearbyArlington, VA, London, San Francisco, CA, New York, NY, Charlottesville, VA, Singapore
- FamilySands Capital Alternatives, LLC · 2 related pages
As an employer
- Offices in3 countries
- Private fundsprivate equity 23, venture capital 11
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Arlington, VA (main office)United States | about 60 |
| Fitzrovia LondonUnited Kingdom | 2 |
| San Francisco, CAUnited States | 2 |
| New York City, NYUnited States | 1 |
| San Juan, PRUnited States | 1 |
| SingaporeSingapore |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| UIPATH INC PATH | $69.3m19.04% | Unchanged |
| DICE THERAPEUTICS INC COM | $48.9m13.42% | Unchanged |
| DOORDASH INC DASH | $38.6m10.60% | Unchanged |
| NU HLDGS LTD NU | $34.2m9.38% | Unchanged |
| SAMSARA, INC. COM CL B | $30.3m8.32% | Unchanged |
| SNOWFLAKE INC SNOW | $29.8m8.20% | Unchanged |
| KARUNA THERAPEUTICS INC COM | $21.9m6.01% | Reduced -95.0k |
| 10X GENOMICS INC TXG | $21.8m5.99% | New |
| CINCOR PHARMA INC COM | $17.9m4.91% | Unchanged |
| ACUMEN PHARMACEUTICALS INC ABOS | $16.1m4.41% | Unchanged |
| OLINK HLDG AB SPONSORED ADS | $10.7m2.94% | Added +280.0k |
| 908 DEVICES INC MASS | $6.7m1.85% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $3.8m1.04% | Unchanged |
| REPLIGEN CORP RGEN | $3.7m1.01% | Unchanged |
| SAMSARA INC IOT | $3.6m1.00% | Unchanged |
| TAYSHA GENE THERAPIES INC TSHA | $2.7m0.74% | Unchanged |
| CANDEL THERAPEUTICS INC CADL | $2.6m0.72% | Unchanged |
| SPRUCE BIOSCIENCES INC COM | $1.4m0.38% | Unchanged |
| ABSCI CORPORATION ABSI | $192.0k0.05% | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 | 5.6%≈ $9.1m |